<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Microbiology, pathogenesis, and epidemiology of relapsing fever</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Microbiology, pathogenesis, and epidemiology of relapsing fever</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Microbiology, pathogenesis, and epidemiology of relapsing fever</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan G Barbour, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 04, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Relapsing fever, which is caused by spirochetes of the genus <em>Borrelia</em>, is characterized by recurrent episodes of fever that accompany spirochetemia. It is an arthropod-borne infection that occurs in two major forms: tick-borne and louse-borne [<a href="#rid1">1,2</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Tick-borne relapsing fever is a zoonosis (ie, an animal disease that is transmissible to humans). The two main <em>Borrelia </em>spp involved in North America are <em>Borrelia hermsii</em> (in the mountainous West) and <em>Borrelia turicatae</em> (in the Southwest and South Central region), although rare cases of human infection with <em>Borrelia parkeri</em> have also been reported in the United States. Other tick-borne species cause relapsing fever on other continents. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Louse-borne relapsing fever is caused by <em>Borrelia recurrentis</em>. It is principally a disease seen in the developing world. It is most commonly spread from person to person by the body louse and can result in large epidemics.</p><p></p><p>The microbiology, pathogenesis, and epidemiology of relapsing fever will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of this disorder, as well as a related spirochete, <em>Borrelia miyamotoi</em>, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/101368.html" rel="external">"Borrelia miyamotoi infection"</a> and  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever"</a>.)</p><p class="headingAnchor" id="H1097132408"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H52444939"><span class="h2">Taxonomy</span><span class="headingEndMark"> — </span>The agents of relapsing fever are spirochetes, a morphologically unique group of bacteria that differ substantially from both gram-negative and gram-positive organisms [<a href="#rid3">3</a>]. Spirochetes can cause a diverse group of diseases, including syphilis, leptospirosis, Lyme disease, and <em>B. miyamotoi</em> infection. (See  <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV"</a> and  <a class="medical medical_review" href="/z/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7901.html" rel="external">"Epidemiology of Lyme disease"</a>.)</p><p>The agents that cause relapsing fever belong to the genus <em>Borrelia</em>, which is in the family <em>Borreliaceae</em> [<a href="#rid4">4-6</a>]. The other genus in the family <em>Borreliaceae</em> is <em>Borreliella </em>(previously known as "<em>Borrelia burgdorferi</em> sensu lato complex"), which includes several species that cause Lyme disease. (See  <a class="medical medical_review" href="/z/d/html/16138.html" rel="external">"Microbiology of Lyme disease"</a>.)</p><p>The genus <em>Borrelia</em> comprises two major clusters classified on the basis of genome relatedness and vector associations: </p><p class="bulletIndent1"><span class="glyph">●</span>The first cluster includes <em>Borrelia</em> spp that are transmitted by soft (or argasid) ticks. Several species can cause tick-borne relapsing fever (TBRF). These species are divided into Old World (or Paleartic and Afrotropical) species, such as <em>B. duttonii, B. crocidurae, </em>and<em> B. hispanica</em>; and New World (or Neartic and Neotropical) species, such as <em>B. hermsii and B. turicatae </em> (<a class="graphic graphic_table graphicRef56833" href="/z/d/graphic/56833.html" rel="external">table 1</a>). It is also likely that additional species exist [<a href="#rid7">7</a>]. (See <a class="local">'Tick-borne relapsing fever'</a> below.)</p><p></p><p class="bulletIndent1">A distinctive member of the first cluster is<em> B. recurrentis</em>, the sole louse-borne agent of relapsing fever.<em> B. recurrentis</em> is closely related <em>to B. duttonii</em> a<em>nd B. crocidurae</em> [<a href="#rid4">4,6,8</a>]. (See <a class="local">'Louse-borne relapsing fever'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The second cluster includes <em>Borrelia</em> spp that are transmitted by hard (or ixodid) ticks, such as those in the genus <em>Amblyomma</em>. They cause an infection of the blood in the vector tick's vertebrate host, including mammals, birds, and reptiles. Only one, <em>B. miyamotoi</em>, is known to cause disease in humans. (See  <a class="medical medical_review" href="/z/d/html/101368.html" rel="external">"Borrelia miyamotoi infection"</a>.)</p><p></p><p class="headingAnchor" id="H1433554504"><span class="h2">Structure and biochemistry of the organisms</span><span class="headingEndMark"> — </span>Spirochetes are wavy or helical in shape and are approximately 0.2 microns in width and 10 to 30 microns in length [<a href="#rid9">9</a>]. Their inner and outer cell membranes are separated by a periplasmic space. One or more flagella are inserted at each end and run the length of the organism through the periplasmic space [<a href="#rid10">10</a>]. </p><p>The spirochetes are too thin to be seen in wet mounts by light microscopy, but can be visualized by phase microscopy or dark field microscopy [<a href="#rid1">1,11</a>]. For fixed blood smears, the spirochetes are detected by Wright or Giemsa stain. Borrelias have fewer and larger amplitude waves than the tightly-coiled treponemes and leptospires. (See  <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Microbiology'</a> and  <a class="medical medical_review" href="/z/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis", section on 'Microbiology'</a>.)</p><p>Borrelias lack a lipopolysaccharide-type endotoxin [<a href="#rid12">12,13</a>]. However, they have an abundance of bacterial lipoproteins that are potent stimulators of proinflammatory cytokines (eg, tumor necrosis factor and interleukin-6) through specific recognition by Toll-like receptors (TLRs), mainly TLR2 [<a href="#rid14">14,15</a>]. These lipoproteins are anchored by fatty acids at their amino-terminal ends, which are embedded in the membrane of the spirochetes.</p><p>A feature of <em>Borreliaceae</em> that distinguishes the family from other spirochetes and most other bacteria is a largely linear genome [<a href="#rid16">16,17</a>]. Each genome consists of a linear chromosome of about 1000 kilobases and different types of linear and circular plasmids.</p><p>A gene that differentiates <em>Borrelia</em> from <em>Borreliella</em> species is glycerophosphodiester phosphodiesterase, or GlpQ [<a href="#rid18">18</a>]. GlpQ is immunogenic and serves as the basis for a subunit immunoassay that serologically discriminates the <em>Borrelia</em> infection relapsing fever and <em>B. miyamotoi</em> disease from the <em>Borreliella</em> infection Lyme disease [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/z/d/html/101368.html" rel="external">"Borrelia miyamotoi infection", section on 'Serology'</a> and  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever", section on 'Serologies'</a>.)</p><p class="headingAnchor" id="H302821251"><span class="h2">Variable major proteins</span><span class="headingEndMark"> — </span>The antigens that determine serotype identity of relapsing fever <em>Borrelia </em>spp are abundant outer membrane lipoproteins called variable major proteins (VMPs) [<a href="#rid20">20,21</a>]. In <em>B. hermsii</em>, for example, there are approximately 30 different VMPs [<a href="#rid22">22</a>]. There can be as little as 30 percent identity in amino acid sequences between two different VMPs of the same strain of a relapsing fever <em>Borrelia </em>spp [<a href="#rid23">23</a>]. This explains the lack of cross-reactivity between antisera raised against different serotypes [<a href="#rid24">24</a>]. (See <a class="local">'Significance of serotypes'</a> below.)</p><p class="headingAnchor" id="H993223551"><span class="h3">Genetics</span><span class="headingEndMark"> — </span>In <em>B. hermsii</em>, there is a complete or near-complete gene for each VMP [<a href="#rid22">22</a>]. Only one VMP gene is expressed at a time in a cell. Expression of this gene occurs at a site near the end of a linear plasmid [<a href="#rid23">23,25</a>]. The other 30 or so VMP genes in the genome are also located on linear plasmids, but they are silent (ie, not expressed in this storage or archival form) [<a href="#rid26">26</a>]. The expression site, unlike the silent sites, has a promoter adjacent to the VMP gene [<a href="#rid27">27</a>].</p><p>During expansion of the population, a different VMP gene replaces the one at the expression site at a frequency of approximately 10<sup>-4</sup> per cell generation [<a href="#rid24">24,28</a>]. In other words, by the time the population size in an infection reaches around 10,000 organisms, a new serotype has probably appeared. The new serotype is still infrequent at the time the host responds to the infecting serotype with an outpouring of IgM antibodies. But the new serotype continues to proliferate while the original infecting serotype is cleared from the blood. Once the second serotype reaches a population size of 10,000 or so organisms in the animal, another one or two serotypes have spontaneously appeared. The antibodies do not cause the change in serotype; they merely select against the majority of cells in the population, allowing new serotypes to predominate.</p><p class="headingAnchor" id="H3570662876"><span class="h3">Mechanisms of gene replacement</span><span class="headingEndMark"> — </span>In <em>B. hermsii</em>, the most common way for a VMP gene at the expression site to be replaced by another VMP gene (thereby switching the serotype of the organism) is recombination between two linear plasmids [<a href="#rid22">22,25,26</a>]. A simplified representation of such a switch in VMP genes is shown in the figure  (<a class="graphic graphic_figure graphicRef66891" href="/z/d/graphic/66891.html" rel="external">figure 1</a>). The boundaries for this recombination are regions of sequence identity between silent and expression sites around and flanking the 5' and 3' ends of the expressed and silent VMP genes [<a href="#rid22">22,28</a>]. </p><p><em>B. hermsii</em> also has another type of VMP, known as the Variable Tick Protein (Vtp); its expression is specifically associated with the tick stage of its life cycle [<a href="#rid29">29,30</a>]. The Vtp gene with its own promoter is located on a different plasmid from those with other VMP genes [<a href="#rid27">27,31</a>]. Sequences of Vtp genes differ between strains and are used to distinguish between <em>B. hermsii</em> strains for epidemiologic purposes [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H2412731579"><span class="h2">Cultivation</span><span class="headingEndMark"> — </span>Borrelias are microaerophilic microorganisms with complex nutritional requirements for growth in cell-free medium [<a href="#rid9">9</a>]. The medium contains serum, glucose, albumin, peptides, amino acids, vitamins, a thickening agent such as gelatin, and, critically, N-acetylglucosamine [<a href="#rid33">33,34</a>]. A commonly used medium is Barbour-Stoenner-Kelly ("BSK") [<a href="#rid35">35</a>], or one its modifications [<a href="#rid36">36</a>]. The generation time is between 5 and 12 hours in BSK media. Otherwise, uncultivable organisms may be isolated and then propagated in immunodeficient mice. </p><p class="headingAnchor" id="H2699890493"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Tick-borne relapsing fever (TBRF) is usually characterized by sporadic cases or small outbreaks that are restricted in their geographic distribution. The risk of infection within a single country or state varies greatly. Travelers returning from endemic areas may develop the disease after return to their homes in other states, provinces, or countries, where physicians may be unfamiliar with the disease [<a href="#rid37">37</a>]. Louse-borne relapsing fever (LBRF) typically occurs as epidemics, and has been seen among refugees and migrants from Africa after their arrival in Europe [<a href="#rid38">38,39</a>].</p><p class="headingAnchor" id="H1153337993"><span class="h2">Tick-borne relapsing fever</span><span class="headingEndMark"> — </span>Tick-borne relapsing fever (TBRF) occurs on every continent except Antarctica, Australia, and the southwest Pacific  (<a class="graphic graphic_table graphicRef56833" href="/z/d/graphic/56833.html" rel="external">table 1</a>). However, it is generally not found in tropical regions or in heavily urban areas. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>North America</strong> – TBRF has been reported in western Canada [<a href="#rid40">40</a>], northern Mexico [<a href="#rid2">2</a>], and the United States. In the United States, TBRF occurs almost exclusively west of the Mississippi River, particularly in the mountainous West and the high deserts and plains of the Southwest  (<a class="graphic graphic_figure graphicRef116940" href="/z/d/graphic/116940.html" rel="external">figure 2</a>) [<a href="#rid41">41</a>]. In the mountainous western United States, the onset of TBRF is most frequent during the summer, while in the Southwest, more cases occur in the late fall or winter. In a survey of 504 cases in the US from 1990 to 2011, TBRF was more common in males (57 percent), and there were peaks in the incidence among persons aged 10 to 14 and 40 to 44 years [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1">The <em>Borrelia</em> species that causes TBRF can vary depending upon the geographic location. As examples:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>B. hermsii</em> typically causes infection in the mountains and foothills of California, Utah, Arizona, New Mexico, Nevada, Colorado, Oregon, and Washington. Infection is often acquired from exposure to cabins in pine forests at altitudes of 1000 to 3100 meters. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>B. turicatae</em> is the usual agent of relapsing fever in the nonmountainous regions of the Southwest (eg, west, north, and central Texas [<a href="#rid42">42,43</a>]) and parts of New Mexico. Common exposures in this region include entering caves and crawling under houses [<a href="#rid2">2,40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Africa </strong>– In Africa, TBRF is caused by <em>B. crocidurae</em>, which is transmitted by <em>Ornithodoros erraticus</em> [<a href="#rid44">44-46</a>], or by <em>B. duttonii</em>, which is transmitted by <em>Ornithodoros moubata</em> [<a href="#rid47">47</a>]. <em>B. crocidurae</em> is more common in western and northern Africa, and <em>B. duttonii</em> is more common in eastern, central, and southern Africa. </p><p></p><p class="bulletIndent1">The incidence of TBRF in Senegal, Mali, and Mauritania of West Africa was evaluated through clinical surveillance and blood testing of individuals with fever from 1990 to 2003 [<a href="#rid48">48</a>]. The average incidence was 11 per 100 person-years, with a range of 4 in 1990 to 25 in 1997. Twenty-six of the 30 studied villages (87 percent) were colonized with the tick vector; the <em>B. crocidurae</em> infection rate of the vector was 31 percent. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other areas </strong>– TBRF has been reported on the Eurasian continent [<a href="#rid49">49</a>]. <em>B. hispanica</em> is present on the Iberian Peninsula and across the Strait of Gibraltar in Morocco [<a href="#rid50">50-52</a>]. <em>Borrelia persica</em> is transmitted by <em>Ornithodoros tholozani</em> ticks in the Middle East (including Israel), Iran, and Central Asia [<a href="#rid53">53-55</a>]. There has been comparatively little study of the epidemiology of <em>Borrelia latyschewii</em> infection in Russia and the former Soviet republics for over three decades. While TBRF from <em>Borrelia venezuelensis</em> has been described in South America [<a href="#rid2">2</a>], there have been few reports of it on that continent.</p><p></p><p class="headingAnchor" id="H4045931395"><span class="h2">Louse-borne relapsing fever</span><span class="headingEndMark"> — </span><em>B. recurrentis</em> remains endemic in Ethiopia and probably exists in the Sudan and Somalia as well [<a href="#rid56">56,57</a>]. The highlands region of Ethiopia has many cases of louse-borne relapsing fever (LBRF) annually; the highest incidence is during the cold rainy season, when individuals with limited resources gather together for shelter and wear more layers of clothes. Lice move from one person to another, thus spreading the infection to new hosts. When LBRF spreads outside the Horn of Africa (eg, to Europe), true epidemics can occur [<a href="#rid58">58</a>]. </p><p>Famine, war, and the movements and congregations of refugees are common predisposing factors for epidemics of LBRF. Under these conditions there is crowding, poor hygiene, few changes of clothing, and lack of access to washing. As an example, the large epidemics of LBRF during the 20<sup>th</sup> century occurred around the two world wars, and millions of people were infected [<a href="#rid2">2</a>]. More recently, LBRF has been identified in refugees from northeast Africa who recently arrived in Europe [<a href="#rid38">38,39,59,60</a>]. </p><p>Homeless people are also highly exposed to body lice in crowded shelters. A prospective study of 930 homeless people in Marseilles, France detected body lice in 22 percent and IgG antibodies to <em>B. recurrentis</em> in 15 (1.6 percent) [<a href="#rid61">61</a>]. </p><p class="headingAnchor" id="H1994990443"><span class="h1">TRANSMISSION</span><span class="headingEndMark"> — </span><em>Borrelia</em> infection most commonly begins after contact with a tick or louse bearing the spirochetes. Transplacental transmission from mother to fetus also occurs [<a href="#rid62">62-64</a>]. Rarely, relapsing fever is acquired through transfusion, accidental inoculation of infected blood, or contact of blood with abraded or lacerated skin, mucous membranes, or the conjunctiva [<a href="#rid65">65</a>]. The incubation period between the exposure and the first fever is between 3 and 12 days.</p><p>Transmission to humans by aerosol, fomites, human saliva, urine, feces, or sexual contact does not occur. In addition, <em>Borrelia </em>spp<em> </em>are susceptible to drying, hypotonic or hypertonic conditions, dilute detergents, and temperatures above 42°C.</p><p>Every known species of <em>Borrelia</em> is host associated; free-living forms have not been found [<a href="#rid9">9</a>]. However, some relapsing fever agents are transmitted vertically in the eggs of the female tick [<a href="#rid66">66,67</a>] and, thereby, may persist in an environment for several years without need for passage through a vertebrate host. </p><p class="headingAnchor" id="H1528373239"><span class="h2">Tick-borne</span></p><p class="headingAnchor" id="H283394608"><span class="h3">Tick vector</span><span class="headingEndMark"> — </span>The usual vectors of tick-borne relapsing fever (TBRF) are argasid ticks (soft ticks), usually of the <em>Ornithodoros</em> genus  (<a class="graphic graphic_figure graphicRef64167" href="/z/d/graphic/64167.html" rel="external">figure 3</a>) [<a href="#rid68">68</a>]. <em>Ornithodoros</em> ticks may live for up to 15 to 20 years and can survive without a blood meal for several years. (See <a class="local">'Risk of acquiring infection'</a> below.)</p><p><em>Ornithodoros</em> ticks usually remain close to or near the habitations of animals (eg, rodents or domestic pigs) and humans [<a href="#rid69">69</a>]. Unlike the tick vectors of Lyme disease and Rocky Mountain spotted fever, they are not found on vegetation, in the forest, or on brush. (See  <a class="medical medical_review" href="/z/d/html/7901.html" rel="external">"Epidemiology of Lyme disease", section on 'Tick vectors'</a> and  <a class="medical medical_review" href="/z/d/html/7902.html" rel="external">"Biology of Rickettsia rickettsii infection", section on 'Tick feeding status'</a>.)</p><p><em>Ornithodoros</em> ticks usually attach to humans residing in or visiting an infested house or other dwelling, or a cave. As an example, in western North America and southwestern United States, relapsing fever has been acquired entering caves, crawling under a building, or sleeping in or near rustic cabins, particularly those built of logs [<a href="#rid41">41,70-73</a>]. They can also attach to individuals sleeping near rodent nests at a campsite. In Africa, the Middle East, and parts of Asia, the ticks live in thatched roofs or in the cracks of mud walls or floors [<a href="#rid44">44,53,74</a>]. (See <a class="local">'Epidemiology'</a> above.) </p><p class="headingAnchor" id="H618811216"><span class="h3">Risk of acquiring infection</span><span class="headingEndMark"> — </span>The risk of relapsing fever after a bite of an infected tick is approximately 50 percent. TBRF is acquired directly through the tick bite and from saliva secreted by the tick into the skin as it feeds. </p><p>For <em>Ornithodoros</em> ticks, the blood feeding itself takes 30 minutes or less and usually occurs at night. Consequently, most people are not aware of being exposed to or bitten by a soft tick. The only sign of an <em>Ornithodoros</em> tick bite may be a small red or violaceous papule with a central eschar that appears within a few days of the exposure. This is in contrast to the ixodid tick vectors, such as those that transmit Lyme disease, which feed for days at a time and attach to people during the day as they move through forested areas or bushy vegetation.</p><p class="headingAnchor" id="H3003000061"><span class="h3">Vertebrate reservoirs</span><span class="headingEndMark"> — </span>TBRF is maintained in the environment by vertebrate reservoirs, which harbor the spirochetes for weeks to months at a time [<a href="#rid1">1</a>]. These are usually rodents, such as chipmunks and tree and ground squirrels in North America [<a href="#rid75">75</a>]; other animal reservoirs include wild and domestic pigs, insectivores, and bats. In some areas of Africa, the natural reservoir for tick-borne <em>B. duttonii</em> includes humans. <em>Ornithodoros</em> ticks usually feed on just one type of animal during their lifetimes [<a href="#rid68">68</a>]. </p><p class="headingAnchor" id="H2077388853"><span class="h2">Louse-borne</span><span class="headingEndMark"> — </span><em>Pediculus humanus corporis</em>, the human body louse, was first recognized as the vector of <em>B. recurrentis </em>in the 19<sup>th</sup> century [<a href="#rid2">2</a>]. It lives on clothing, not on the skin or hair [<a href="#rid76">76,77</a>]. The body louse coevolved with hominids and feeds only on humans. Lice must have frequent blood meals since they have a lifespan measured in weeks (unlike ticks that can live for years). <em>B. recurrentis</em> has also been found in<em> Pediculus humanus capitus</em> (the head louse), but its role in transmission has not been determined [<a href="#rid78">78</a>]. </p><p><em>B. recurrentis</em> grows in the body cavity of the louse but does not appear in the saliva or feces. When people crush a louse with their fingers, the organism is introduced at the bite site, into the skin of the crushing fingers, or into the conjunctivae when they rub their eyes. Nonhuman primates can also be infected with <em>B. recurrentis</em>; however, humans are probably the only reservoir of <em>B. recurrentis</em>.</p><p class="headingAnchor" id="H1527823676"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Relapsing fever is primarily an extracellular infection of the bloodstream. Involvement of other organs, such as the central nervous system, the eye, and the liver, are the consequence of the large numbers of intravascular organisms migrating into tissues. </p><p class="headingAnchor" id="H8"><span class="h2">Initiation of infection and mechanism of relapse</span><span class="headingEndMark"> — </span>A single spirochete may be sufficient to initiate an infection [<a href="#rid79">79</a>]. Once in the blood, the borrelias divide every 6 to 12 hours until they number 10<sup>6</sup> to 10<sup>8</sup> per mL of blood. The spirochetes move through or between endothelial cells as they leave the blood to invade the brain, eye, inner ear, liver, heart, testes, and other organs [<a href="#rid80">80-82</a>]. Although blood is the main site of replication during the acute illness, borrelias do not proliferate inside of endothelial or phagocytic cells [<a href="#rid83">83</a>]. </p><p>During recurrence of fever, spirochetes can be easily seen by microscopic examination of the blood. They may be as numerous as erythrocytes on blood smears. Between febrile periods, borrelias<em> </em>do not completely disappear from the blood, but their numbers diminish to the point at which they are undetectable by microscopic examination of blood smears [<a href="#rid24">24</a>].</p><p>Antigenic variation accounts for the reappearance of spirochetes in the blood and the relapses of illness [<a href="#rid83">83</a>]. By changing a major antigen on its surface, the <em>Borrelia</em> population is able to stay one step ahead of the host adaptive immune response. Other vector-borne pathogens that use the strategy of multiphasic antigenic variation as a strategy to evade specific immunity are trypanosomes that cause African trypanosomiasis and <em>Plasmodium</em> species that cause malaria. (See  <a class="medical medical_review" href="/z/d/html/5688.html" rel="external">"Human African trypanosomiasis: Treatment and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/5703.html" rel="external">"Pathogenesis of malaria"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Significance of serotypes</span><span class="headingEndMark"> — </span>The antigens that determine serotype identity of relapsing fever <em>Borrelia </em>spp are abundant outer membrane lipoproteins called variable major proteins (VMPs). A detailed discussion of VMPs is found above. (See <a class="local">'Variable major proteins'</a> above.) </p><p>A single strain of a relapsing fever <em>Borrelia</em> species is able to produce several antigenically distinct variants called serotypes [<a href="#rid22">22</a>]. As an example, a mouse or human infected with one strain of relapsing fever <em>Borrelia </em>species may initially have serotype A in the blood, then have serotype B during the first relapse, and finally serotype C during a second relapse [<a href="#rid84">84</a>]. The order of serotype appearance is not rigidly fixed and is reversible. For instance, it may be A to B to C in one host, and B to A to C in another [<a href="#rid28">28</a>]. In passive transfer experiments, antiserum raised to a specific serotype (eg, A) protects mice against challenges with the homologous serotype but not against other serotypes (eg, B or C) [<a href="#rid24">24,85</a>]. </p><p class="headingAnchor" id="H2892912236"><span class="h2">Other pathogenetic mechanisms</span><span class="headingEndMark"> — </span>During relapsing fever, there may be adherence of the spirochetes in the blood to erythrocytes or platelets [<a href="#rid86">86,87</a>]. This produces microaggregates that accumulate in small vessels, leading to organ dysfunction and splenomegaly. In addition, complement-mediated killing may be thwarted by different bacterial surface proteins that bind and tie up complement factors or regulators [<a href="#rid88">88-90</a>].</p><p class="headingAnchor" id="H2248604280"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Spirochetes have been found in the spleen, liver, brain, eye, and kidney at the time of autopsy in patients with relapsing fever and at the time of necropsy in experimentally infected animals [<a href="#rid58">58,91,92</a>]. <em>Borrelia</em> spp<em> </em>can be detected in tissue sections with silver stains, such as Warthin-Starry or modified Dieterle, by immunofluorescence with conjugated antibodies [<a href="#rid93">93-95</a>], or with polymerase chain reaction [<a href="#rid11">11,96,97</a>]. (See  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever", section on 'Diagnostic methods'</a>.)</p><p>The severity of relapsing fever generally correlates directly with the numbers (concentration) of spirochetes in the blood [<a href="#rid94">94</a>]. Gross findings in fatal cases of relapsing fever usually include widespread petechial hemorrhages, enlarged spleen and liver, and an edematous, congested brain [<a href="#rid58">58,91</a>]. The most common histologic findings at autopsy are swelling of endothelial cells, microvascular leakage, perivascular mononuclear cell infiltrates, microabscesses, and hemorrhages. </p><p>Fatal cases of louse-borne relapsing fever frequently have myocarditis with histiocytic infiltrates and microhemorrhages. The spleen and liver, but not the kidneys or adrenals, often have focal areas of necrosis. Although bleeding is a common complication of louse-borne relapsing fever, evidence of intravascular coagulation is not prominent. </p><p class="headingAnchor" id="H14"><span class="h1">IMMUNITY</span><span class="headingEndMark"> — </span>IgM antibodies alone are sufficient to limit infection in infected animals [<a href="#rid85">85,98</a>]. Because specific antibodies to outer membrane proteins can kill these spirochetes in the absence of complement or phagocytes [<a href="#rid99">99</a>], deficiencies in the latter immune effectors may not be a major handicap to clearing borrelias from the blood. By contrast, absence of a spleen and impaired B-cell function may increase the severity of disease and prolong infection. (See  <a class="medical medical_review" href="/z/d/html/3914.html" rel="external">"Primary humoral immunodeficiencies: An overview"</a>.)</p><p>Humans and other animals produce antibodies to a number of different components of the spirochetes during infection, including the glycerophosphodiester phosphodiesterase (GlpQ) protein [<a href="#rid19">19</a>]. However, only antibodies directed against the variable major proteins appear to be effective in controlling the disease [<a href="#rid83">83</a>]. (See <a class="local">'Variable major proteins'</a> above.) </p><p>Spirochetes are cleared from the blood with increasing concentrations of neutralizing antibodies in the serum. While antibodies alone may be sufficient, lysis of borrelias in the blood or spleen may be more rapid after opsonization and complement fixation [<a href="#rid100">100</a>]. This event is often accompanied by a "crisis," or worsening condition of the patient. This crisis phenomenon with fever and hypotension during relapsing fever is very similar to the Jarisch-Herxheimer reaction, which occurs soon after the start of antibiotic therapy [<a href="#rid101">101,102</a>]. (See  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Relapsing fever, caused by spirochetes of the <em>Borrelia </em>genus, is an arthropod-borne infection that occurs in two major forms: tick-borne (TBRF) and louse-borne (LBRF). As the name implies, relapsing fever is characterized by recurrent episodes of fever that accompany spirochetemia. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Borrelia recurrentis</em> is the sole agent of LBRF. In contrast, there are at least 10 species that can cause TBRF; the two main ones in North America are <em>Borrelia hermsii</em> and <em>Borrelia turicatae</em>. (See <a class="local">'Taxonomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most members of the <em>Borrelia</em> genus are approximately 0.2 microns in width and 10 to 30 microns in length. They can be visualized by phase microscopy or dark field microscopy. For fixed blood smears, the spirochetes are detected by Wright or Giemsa stain. (See <a class="local">'Structure and biochemistry of the organisms'</a> above and <a class="local">'Cultivation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TBRF is usually characterized by sporadic cases or small outbreaks that are restricted in their geographic distributions. By contrast, LBRF often occurs as epidemics; famine, war, and the movement and congregation of refugees are common predisposing factors. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The usual vectors of TBRF are argasid ticks of the <em>Ornithodoros </em>genus. The risk of acquiring relapsing fever after a bite from an infected tick is approximately 50 percent. The blood feeding itself takes 30 minutes or less and usually occurs at night. (See <a class="local">'Tick-borne'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The vector of <em>B. recurrentis</em> is the body louse, <em>Pediculus humanus corporis</em>, which only feeds on humans. (See <a class="local">'Louse-borne'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Borrelia</em> infection begins with contact with a tick or louse bearing the spirochetes. Antigenic variation accounts for the reappearance of spirochetes in the blood, which also correlates with relapses of illness. By changing a major antigen on its surface, the <em>Borrelia</em> population is able to evade the host immune response. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Humans and other animals produce antibodies to a number of different components of the spirochetes during infection. However, only antibodies directed against the variable membrane proteins appear to be effective in controlling the disease. Spirochetes are cleared from the blood with increasing concentrations of neutralizing antibodies in the serum. (See <a class="local">'Immunity'</a> above and <a class="local">'Variable major proteins'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Barbour A. Relapsing fever. In: Tick-borne Diseases of Humans, Dennis DT, Goodman JL, Sonenshine DE (Eds), ASM Press, Washington DC 2005. p.220.</li><li class="breakAll">Barbour AG, Guo BP. Borrelia. In: Molecular Biology, Host Interaction, and Pathogenesis, Samuels DS, Radolf JD (Eds), Caister Academic Press, Norfolk, United Kingdom 2010. p.333.</li><li><a class="nounderline abstract_t">Paster BJ, Dewhirst FE, Weisburg WG, et al. Phylogenetic analysis of the spirochetes. J Bacteriol 1991; 173:6101.</a></li><li><a class="nounderline abstract_t">Barbour AG. Phylogeny of a relapsing fever Borrelia species transmitted by the hard tick Ixodes scapularis. Infect Genet Evol 2014; 27:551.</a></li><li class="breakAll">Barbour AG. Borreliaceae. In: Bergey's Manual of Systematics of Archaea and Bacteria, Trujillo ME, Dedysh S, DeVos P, et al (Eds), Wiley, 2018.</li><li class="breakAll">Barbour AG, Schwan TG. Borrelia. In: Bergey's Manual of Systematics of Archaea and Bacteria, Trujillo ME, Dedysh S, DeVos P, et al (Eds), Wiley, 2018.</li><li><a class="nounderline abstract_t">Kisinza WN, McCall PJ, Mitani H, et al. A newly identified tick-borne Borrelia species and relapsing fever in Tanzania. Lancet 2003; 362:1283.</a></li><li><a class="nounderline abstract_t">Lescot M, Audic S, Robert C, et al. The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet 2008; 4:e1000185.</a></li><li><a class="nounderline abstract_t">Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986; 50:381.</a></li><li><a class="nounderline abstract_t">Holt SC. Anatomy and chemistry of spirochetes. Microbiol Rev 1978; 42:114.</a></li><li class="breakAll">Barbour AG. Relapsing Fever and Other Borrelia Infections. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.295.</li><li><a class="nounderline abstract_t">Takayama K, Rothenberg RJ, Barbour AG. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 1987; 55:2311.</a></li><li><a class="nounderline abstract_t">Hardy PH Jr, Levin J. Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proc Soc Exp Biol Med 1983; 174:47.</a></li><li><a class="nounderline abstract_t">Hirschfeld M, Kirschning CJ, Schwandner R, et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999; 163:2382.</a></li><li><a class="nounderline abstract_t">Londoño D, Cadavid D. Bacterial lipoproteins can disseminate from the periphery to inflame the brain. Am J Pathol 2010; 176:2848.</a></li><li><a class="nounderline abstract_t">Ferdows MS, Barbour AG. Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A 1989; 86:5969.</a></li><li><a class="nounderline abstract_t">Casjens S. Evolution of the linear DNA replicons of the Borrelia spirochetes. Curr Opin Microbiol 1999; 2:529.</a></li><li><a class="nounderline abstract_t">Schwan TG, Battisti JM, Porcella SF, et al. Glycerol-3-phosphate acquisition in spirochetes: distribution and biological activity of glycerophosphodiester phosphodiesterase (GlpQ) among Borrelia species. J Bacteriol 2003; 185:1346.</a></li><li><a class="nounderline abstract_t">Schwan TG, Schrumpf ME, Hinnebusch BJ, et al. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol 1996; 34:2483.</a></li><li><a class="nounderline abstract_t">Barbour AG, Tessier SL, Stoenner HG. Variable major proteins of Borrellia hermsii. J Exp Med 1982; 156:1312.</a></li><li><a class="nounderline abstract_t">Burman N, Bergström S, Restrepo BI, Barbour AG. The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol 1990; 4:1715.</a></li><li><a class="nounderline abstract_t">Dai Q, Restrepo BI, Porcella SF, et al. Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids. Mol Microbiol 2006; 60:1329.</a></li><li><a class="nounderline abstract_t">Restrepo BI, Kitten T, Carter CJ, et al. Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol 1992; 6:3299.</a></li><li><a class="nounderline abstract_t">Stoenner HG, Dodd T, Larsen C. Antigenic variation of Borrelia hermsii. J Exp Med 1982; 156:1297.</a></li><li><a class="nounderline abstract_t">Kitten T, Barbour AG. Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A 1990; 87:6077.</a></li><li><a class="nounderline abstract_t">Plasterk RH, Simon MI, Barbour AG. Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature 1985; 318:257.</a></li><li><a class="nounderline abstract_t">Barbour AG, Burman N, Carter CJ, et al. Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol 1991; 5:489.</a></li><li><a class="nounderline abstract_t">Barbour AG, Dai Q, Restrepo BI, et al. Pathogen escape from host immunity by a genome program for antigenic variation. Proc Natl Acad Sci U S A 2006; 103:18290.</a></li><li><a class="nounderline abstract_t">Schwan TG, Hinnebusch BJ. Bloodstream- versus tick-associated variants of a relapsing fever bacterium. Science 1998; 280:1938.</a></li><li><a class="nounderline abstract_t">Schwan TG, Piesman J. Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis 2002; 8:115.</a></li><li><a class="nounderline abstract_t">Carter CJ, Bergström S, Norris SJ, Barbour AG. A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun 1994; 62:2792.</a></li><li><a class="nounderline abstract_t">Porcella SF, Raffel SJ, Anderson DE Jr, et al. Variable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North America. Infect Immun 2005; 73:6647.</a></li><li><a class="nounderline abstract_t">Kelly R. Cultivation of Borrelia hermsi. Science 1971; 173:443.</a></li><li><a class="nounderline abstract_t">Stoenner HG. Biology of Borrelia hermsii in Kelly medium. Appl Microbiol 1974; 28:540.</a></li><li><a class="nounderline abstract_t">Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57:521.</a></li><li><a class="nounderline abstract_t">Cutler SJ, Akintunde CO, Moss J, et al. Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis. Int J Syst Bacteriol 1999; 49 Pt 4:1793.</a></li><li><a class="nounderline abstract_t">Colebunders R, De Serrano P, Van Gompel A, et al. Imported relapsing fever in European tourists. Scand J Infect Dis 1993; 25:533.</a></li><li><a class="nounderline abstract_t">Colomba C, Scarlata F, Di Carlo P, et al. Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article. Public Health 2016; 139:22.</a></li><li><a class="nounderline abstract_t">Hoch M, Wieser A, Löscher T, et al. Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015. Euro Surveill 2015; 20.</a></li><li><a class="nounderline abstract_t">Banerjee SN, Banerjee M, Fernando K, et al. Tick-borne relapsing fever in British Columbia, Canada: first isolation of Borrelia hermsii. J Clin Microbiol 1998; 36:3505.</a></li><li><a class="nounderline abstract_t">Forrester JD, Kjemtrup AM, Fritz CL, et al. Tickborne relapsing fever - United States, 1990-2011. MMWR Morb Mortal Wkly Rep 2015; 64:58.</a></li><li><a class="nounderline abstract_t">Krishnavajhala A, Armstrong BA, Kneubehl AR, et al. Diversity and distribution of the tick-borne relapsing fever spirochete Borrelia turicatae. PLoS Negl Trop Dis 2021; 15:e0009868.</a></li><li><a class="nounderline abstract_t">Ellis L, Curtis MW, Gunter SM, Lopez JE. Relapsing Fever Infection Manifesting as Aseptic Meningitis, Texas, USA. Emerg Infect Dis 2021; 27.</a></li><li><a class="nounderline abstract_t">Trape JF, Diatta G, Arnathau C, et al. The epidemiology and geographic distribution of relapsing fever borreliosis in West and North Africa, with a review of the Ornithodoros erraticus complex (Acari: Ixodida). PLoS One 2013; 8:e78473.</a></li><li><a class="nounderline abstract_t">Schwan TG, Anderson JM, Lopez JE, et al. Endemic foci of the tick-borne relapsing fever spirochete Borrelia crocidurae in Mali, West Africa, and the potential for human infection. PLoS Negl Trop Dis 2012; 6:e1924.</a></li><li><a class="nounderline abstract_t">Souidi Y, Boudebouch N, Ezikouri S, et al. Borrelia crocidurae in Ornithodoros ticks from northwestern Morocco: a range extension in relation to climatic change? J Vector Ecol 2014; 39:316.</a></li><li><a class="nounderline abstract_t">Cutler SJ, Bonilla EM, Singh RJ. Population structure of East African relapsing fever Borrelia spp. Emerg Infect Dis 2010; 16:1076.</a></li><li><a class="nounderline abstract_t">Vial L, Diatta G, Tall A, et al. Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet 2006; 368:37.</a></li><li><a class="nounderline abstract_t">Assous MV, Wilamowski A. Relapsing fever borreliosis in Eurasia--forgotten, but certainly not gone! Clin Microbiol Infect 2009; 15:407.</a></li><li><a class="nounderline abstract_t">Sarih M, Garnier M, Boudebouch N, et al. Borrelia hispanica relapsing fever, Morocco. Emerg Infect Dis 2009; 15:1626.</a></li><li><a class="nounderline abstract_t">Toledo A, Anda P, Escudero R, et al. Phylogenetic analysis of a virulent Borrelia species isolated from patients with relapsing fever. J Clin Microbiol 2010; 48:2484.</a></li><li><a class="nounderline abstract_t">Domínguez MC, Vergara S, Gómez MC, Roldán ME. Epidemiology of Tick-Borne Relapsing Fever in Endemic Area, Spain. Emerg Infect Dis 2020; 26:849.</a></li><li><a class="nounderline abstract_t">Colin de Verdiere N, Hamane S, Assous MV, et al. Tickborne relapsing fever caused by Borrelia persica, Uzbekistan and Tajikistan. Emerg Infect Dis 2011; 17:1325.</a></li><li><a class="nounderline abstract_t">Moemenbellah-Fard MD, Benafshi O, Rafinejad J, Ashraf H. Tick-borne relapsing fever in a new highland endemic focus of western Iran. Ann Trop Med Parasitol 2009; 103:529.</a></li><li><a class="nounderline abstract_t">Halperin T, Orr N, Cohen R, et al. Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene. Acta Trop 2006; 98:189.</a></li><li><a class="nounderline abstract_t">Yimer M, Abera B, Mulu W, et al. Prevalence and risk factors of louse-borne relapsing fever in high risk populations in Bahir Dar city Northwest, Ethiopia. BMC Res Notes 2014; 7:615.</a></li><li><a class="nounderline abstract_t">Cutler SJ. Possibilities for relapsing fever reemergence. Emerg Infect Dis 2006; 12:369.</a></li><li><a class="nounderline abstract_t">Bryceson AD, Parry EH, Perine PL, et al. Louse-borne relapsing fever. Q J Med 1970; 39:129.</a></li><li><a class="nounderline abstract_t">Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis 2016; 14:110.</a></li><li><a class="nounderline abstract_t">Osthoff M, Schibli A, Fadini D, et al. Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015. BMC Infect Dis 2016; 16:210.</a></li><li><a class="nounderline abstract_t">Brouqui P, Stein A, Dupont HT, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore) 2005; 84:61.</a></li><li><a class="nounderline abstract_t">Jongen VH, van Roosmalen J, Tiems J, et al. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand 1997; 76:834.</a></li><li><a class="nounderline abstract_t">Larsson C, Andersson M, Guo BP, et al. Complications of pregnancy and transplacental transmission of relapsing-fever borreliosis. J Infect Dis 2006; 194:1367.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Tickborne relapsing fever in a mother and newborn child--Colorado, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:174.</a></li><li><a class="nounderline abstract_t">López-Cortés L, Lozano de León F, Gómez-Mateos JM, et al. Tick-borne relapsing fever in intravenous drug abusers. J Infect Dis 1989; 159:804.</a></li><li><a class="nounderline abstract_t">Burgdorfer W, Varma MG. Trans-stadial and transovarial development of disease agents in arthropods. Annu Rev Entomol 1967; 12:347.</a></li><li><a class="nounderline abstract_t">Rollend L, Fish D, Childs JE. Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: a summary of the literature and recent observations. Ticks Tick Borne Dis 2013; 4:46.</a></li><li class="breakAll">Sonenshine DE, Anderson JM. Biology of Ticks, Sonenshine DE, Roe RM (Eds), Oxford University Press, New York City 2014.</li><li class="breakAll">Manzano-Roman R, Diaz-Martin V, de la Fuente J, Perez-Sanchez R. Soft ticks as pathogen vectors: Distribution, surveillance and control. In: Parasitology, Shah MM (Ed), InTech, Rijeka 2012.</li><li><a class="nounderline abstract_t">Dworkin MS, Schwan TG, Anderson DE Jr. Tick-borne relapsing fever in North America. Med Clin North Am 2002; 86:417.</a></li><li><a class="nounderline abstract_t">Wilder HK, Wozniak E, Huddleston E, et al. Case report: A retrospective serological analysis indicating human exposure to tick-borne relapsing fever spirochetes in Texas. PLoS Negl Trop Dis 2015; 9:e0003617.</a></li><li><a class="nounderline abstract_t">Christensen J, Fischer RJ, McCoy BN, et al. Tickborne relapsing fever, Bitterroot Valley, Montana, USA. Emerg Infect Dis 2015; 21:217.</a></li><li><a class="nounderline abstract_t">Mafi N, Yaglom HD, Levy C, et al. Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013-2018. Emerg Infect Dis 2019; 25:649.</a></li><li><a class="nounderline abstract_t">Masoumi Asl H, Goya MM, Vatandoost H, et al. The epidemiology of tick-borne relapsing fever in Iran during 1997-2006. Travel Med Infect Dis 2009; 7:160.</a></li><li><a class="nounderline abstract_t">Foley JE, Nieto NC. The ecology of tick-transmitted infections in the redwood chipmunk (Tamias ochrogenys). Ticks Tick Borne Dis 2011; 2:88.</a></li><li><a class="nounderline abstract_t">Bonilla DL, Durden LA, Eremeeva ME, Dasch GA. The biology and taxonomy of head and body lice--implications for louse-borne disease prevention. PLoS Pathog 2013; 9:e1003724.</a></li><li><a class="nounderline abstract_t">Boutellis A, Abi-Rached L, Raoult D. The origin and distribution of human lice in the world. Infect Genet Evol 2014; 23:209.</a></li><li><a class="nounderline abstract_t">Boutellis A, Mediannikov O, Bilcha KD, et al. Borrelia recurrentis in head lice, Ethiopia. Emerg Infect Dis 2013; 19:796.</a></li><li><a class="nounderline abstract_t">SCHUHARDT VT, WILKERSON M. Relapse phenomena in rats infected with single spirochetes (Borrelia recurrentis var. turicatae). J Bacteriol 1951; 62:215.</a></li><li><a class="nounderline abstract_t">Cadavid D, Bundoc V, Barbour AG. Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis 1993; 168:143.</a></li><li><a class="nounderline abstract_t">Cadavid D, Thomas DD, Crawley R, Barbour AG. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 1994; 179:631.</a></li><li><a class="nounderline abstract_t">Shamaei-Tousi A, Burns MJ, Benach JL, et al. The relapsing fever spirochaete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils. Cell Microbiol 2000; 2:591.</a></li><li class="breakAll">Barbour AG, Guo BP. Pathogenesis of relapsing fever. In: Molecular and Cellular Biology, Samuels F, Radolf J (Eds), Horizon Scientific Press, Norwich 2009.</li><li><a class="nounderline abstract_t">Coffey EM, Eveland WC. Experimental relapsing fever initiated by Borrelia hermsi. II. Sequential appearance of major serotypes in the rat. J Infect Dis 1967; 117:29.</a></li><li><a class="nounderline abstract_t">Barbour AG, Bundoc V. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun 2001; 69:1009.</a></li><li><a class="nounderline abstract_t">Shamaei-Tousi A, Collin O, Bergh A, Bergström S. Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection. J Exp Med 2001; 193:995.</a></li><li><a class="nounderline abstract_t">Shamaei-Tousi A, Martin P, Bergh A, et al. Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli. J Infect Dis 1999; 180:1929.</a></li><li><a class="nounderline abstract_t">Hovis KM, McDowell JV, Griffin L, Marconi RT. Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol 2004; 186:2612.</a></li><li><a class="nounderline abstract_t">Rossmann E, Kraiczy P, Herzberger P, et al. Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes. J Immunol 2007; 178:7292.</a></li><li><a class="nounderline abstract_t">Lewis ER, Marcsisin RA, Campeau Miller SA, et al. Fibronectin-binding protein of Borrelia hermsii expressed in the blood of mice with relapsing fever. Infect Immun 2014; 82:2520.</a></li><li><a class="nounderline abstract_t">Southern P, Sanford J. Relapsing fever: A clinical and microbiological review. Medicine 1969; 48:129.</a></li><li><a class="nounderline abstract_t">Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998; 26:151.</a></li><li><a class="nounderline abstract_t">Duray PH. The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol 1987; 11 Suppl 1:47.</a></li><li><a class="nounderline abstract_t">Pennington PM, Allred CD, West CS, et al. Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun 1997; 65:285.</a></li><li><a class="nounderline abstract_t">Park HK, Jones BE, Barbour AG. Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies. J Am Acad Dermatol 1986; 15:406.</a></li><li class="breakAll">Barbour AG. Relapsing fever. In: Harrison's Principle of Internal Medicine, 19th ed, Kasper DL, Hauser SL, Longo DL, et al (Eds), McGraw Hill, New York City 2015.</li><li><a class="nounderline abstract_t">Elbir H, Henry M, Diatta G, et al. Multiplex real-time PCR diagnostic of relapsing fevers in Africa. PLoS Negl Trop Dis 2013; 7:e2042.</a></li><li><a class="nounderline abstract_t">Newman K Jr, Johnson RC. T-cell-independent elimination of Borrelia turicatae. Infect Immun 1984; 45:572.</a></li><li><a class="nounderline abstract_t">LaRocca TJ, Katona LI, Thanassi DG, Benach JL. Bactericidal action of a complement-independent antibody against relapsing fever Borrelia resides in its variable region. J Immunol 2008; 180:6222.</a></li><li><a class="nounderline abstract_t">Barbour AG. Immunobiology of relapsing fever. Contrib Microbiol Immunol 1987; 8:125.</a></li><li><a class="nounderline abstract_t">Bryceson AD. Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis 1976; 133:696.</a></li><li><a class="nounderline abstract_t">Negussie Y, Remick DG, DeForge LE, et al. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J Exp Med 1992; 175:1207.</a></li></ol></div><div id="topicVersionRevision">Topic 7898 Version 13.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Barbour A. Relapsing fever. In: Tick-borne Diseases of Humans, Dennis DT, Goodman JL, Sonenshine DE (Eds), ASM Press, Washington DC 2005. p.220.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Barbour AG, Guo BP. Borrelia. In: Molecular Biology, Host Interaction, and Pathogenesis, Samuels DS, Radolf JD (Eds), Caister Academic Press, Norfolk, United Kingdom 2010. p.333.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1917844" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Phylogenetic analysis of the spirochetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24813576" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Phylogeny of a relapsing fever Borrelia species transmitted by the hard tick Ixodes scapularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24813576" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Phylogeny of a relapsing fever Borrelia species transmitted by the hard tick Ixodes scapularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24813576" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Phylogeny of a relapsing fever Borrelia species transmitted by the hard tick Ixodes scapularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14575974" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A newly identified tick-borne Borrelia species and relapsing fever in Tanzania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18787695" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3540570" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Biology of Borrelia species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/379570" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Anatomy and chemistry of spirochetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/379570" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Anatomy and chemistry of spirochetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3623705" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6356134" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Lack of endotoxin in Borrelia hispanica and Treponema pallidum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10452971" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20431027" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bacterial lipoproteins can disseminate from the periphery to inflame the brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2762306" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10508719" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Evolution of the linear DNA replicons of the Borrelia spirochetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12562805" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Glycerol-3-phosphate acquisition in spirochetes: distribution and biological activity of glycerophosphodiester phosphodiesterase (GlpQ) among Borrelia species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8880505" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7130901" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Variable major proteins of Borrellia hermsii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1706456" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16796672" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1484486" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7130900" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Antigenic variation of Borrelia hermsii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2385585" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4069202" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2041480" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17101971" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pathogen escape from host immunity by a genome program for antigenic variation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9632392" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bloodstream- versus tick-associated variants of a relapsing fever bacterium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11897061" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8005669" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16177341" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Variable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5557322" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cultivation of Borrelia hermsi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4472988" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Biology of Borrelia hermsii in Kelly medium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6393604" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Isolation and cultivation of Lyme disease spirochetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10555362" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8248757" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Imported relapsing fever in European tourists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27340042" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26538532" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9817862" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Tick-borne relapsing fever in British Columbia, Canada: first isolation of Borrelia hermsii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25632952" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Tickborne relapsing fever - United States, 1990-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34813588" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Diversity and distribution of the tick-borne relapsing fever spirochete Borrelia turicatae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34546167" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Relapsing Fever Infection Manifesting as Aseptic Meningitis, Texas, USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24223812" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The epidemiology and geographic distribution of relapsing fever borreliosis in West and North Africa, with a review of the Ornithodoros erraticus complex (Acari: Ixodida).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23209863" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Endemic foci of the tick-borne relapsing fever spirochete Borrelia crocidurae in Mali, West Africa, and the potential for human infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25424260" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Borrelia crocidurae in Ornithodoros ticks from northwestern Morocco: a range extension in relation to climatic change?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20587177" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Population structure of East African relapsing fever Borrelia spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16815378" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Incidence of tick-borne relapsing fever in west Africa: longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19489923" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Relapsing fever borreliosis in Eurasia--forgotten, but certainly not gone!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19861058" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Borrelia hispanica relapsing fever, Morocco.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20463158" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Phylogenetic analysis of a virulent Borrelia species isolated from patients with relapsing fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32308194" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Epidemiology of Tick-Borne Relapsing Fever in Endemic Area, Spain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21762608" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Tickborne relapsing fever caused by Borrelia persica, Uzbekistan and Tajikistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19695158" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Tick-borne relapsing fever in a new highland endemic focus of western Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16729949" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25196787" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prevalence and risk factors of louse-borne relapsing fever in high risk populations in Bahir Dar city Northwest, Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16704771" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Possibilities for relapsing fever reemergence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4913454" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Louse-borne relapsing fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26872415" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Louse-borne relapsing fever among East African refugees in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27188655" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15643300" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9351408" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Tick-borne relapsing fever and pregnancy outcome in rural Tanzania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17054065" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Complications of pregnancy and transplacental transmission of relapsing-fever borreliosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22419050" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Tickborne relapsing fever in a mother and newborn child--Colorado, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2926174" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Tick-borne relapsing fever in intravenous drug abusers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5340722" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Trans-stadial and transovarial development of disease agents in arthropods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23238242" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: a summary of the literature and recent observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23238242" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: a summary of the literature and recent observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23238242" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: a summary of the literature and recent observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11982310" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Tick-borne relapsing fever in North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25856342" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Case report: A retrospective serological analysis indicating human exposure to tick-borne relapsing fever spirochetes in Texas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25625502" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Tickborne relapsing fever, Bitterroot Valley, Montana, USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30882304" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19411042" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The epidemiology of tick-borne relapsing fever in Iran during 1997-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21643481" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The ecology of tick-transmitted infections in the redwood chipmunk (Tamias ochrogenys).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24244157" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The biology and taxonomy of head and body lice--implications for louse-borne disease prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24524985" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The origin and distribution of human lice in the world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23648147" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Borrelia recurrentis in head lice, Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14861181" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Relapse phenomena in rats infected with single spirochetes (Borrelia recurrentis var. turicatae).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8515101" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8294872" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11207611" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The relapsing fever spirochaete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11207611" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The relapsing fever spirochaete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5338694" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Experimental relapsing fever initiated by Borrelia hermsi. II. Sequential appearance of major serotypes in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11159997" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11342584" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10558950" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15090501" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17513779" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24686059" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Fibronectin-binding protein of Borrelia hermsii expressed in the blood of mice with relapsing fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Relapsing fever: A clinical and microbiological review</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9455525" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3812878" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The surgical pathology of human Lyme disease. An enlarging picture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8975925" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2426315" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2426315" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23390560" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Multiplex real-time PCR diagnostic of relapsing fevers in Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6332075" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : T-cell-independent elimination of Borrelia turicatae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18424744" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Bactericidal action of a complement-independent antibody against relapsing fever Borrelia resides in its variable region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3304829" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Immunobiology of relapsing fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/932495" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Clinical pathology of the Jarisch-Herxheimer reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1569394" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
